|
12
|
54
|
2ei8B |
Factor xa in complex with the inhibitor (1s,2r,4s)-n1-[(5-chloroindol-2-yl)carbonyl]-4-(n,n-dimethylcarbamoyl)-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
58
|
233
|
2ei6A |
Factor xa in complex with the inhibitor (-)-cis-n1-[(5-chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
60
|
233
|
2ei7A |
Factor xa in complex with the inhibitor trans-n1-[(5-chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
11
|
54
|
2ei7B |
Factor xa in complex with the inhibitor trans-n1-[(5-chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
63
|
233
|
2ei8A |
Factor xa in complex with the inhibitor (1s,2r,4s)-n1-[(5-chloroindol-2-yl)carbonyl]-4-(n,n-dimethylcarbamoyl)-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
12
|
54
|
2ei6B |
Factor xa in complex with the inhibitor (-)-cis-n1-[(5-chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
12
|
52
|
2cjiB |
Crystal structure of a human factor xa inhibitor complex |
|
12
|
54
|
2d1jB |
Factor xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide |
|
58
|
233
|
2d1jA |
Factor xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide |
|
58
|
234
|
2cjiA |
Crystal structure of a human factor xa inhibitor complex |
|
60
|
234
|
2bqwB |
Crystal structure of factor xa in complex with compound 45 |
|
10
|
53
|
2bmgA |
Crystal structure of factor xa in complex with 50 |
|
61
|
234
|
2bq6B |
Crystal structure of factor xa in complex with 21 |
|
56
|
233
|
2bokA |
Factor xa - cation |
|
10
|
52
|
2bq6A |
Crystal structure of factor xa in complex with 21 |
|
12
|
51
|
2bokL |
Factor xa - cation |
|
11
|
53
|
2bohA |
Crystal structure of factor xa in complex with compound "1" |
|
11
|
52
|
2bq7A |
Crystal structure of factor xa in complex with 43 |
|
60
|
234
|
2bohB |
Crystal structure of factor xa in complex with compound "1" |
|
63
|
234
|
2bq7B |
Crystal structure of factor xa in complex with 43 |
|
12
|
52
|
2bqwA |
Crystal structure of factor xa in complex with compound 45 |
|
59
|
234
|
2bmgB |
Crystal structure of factor xa in complex with 50 |
|
13
|
52
|
1z6eL |
Factor xa in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; dpc906; bms-561389) |
|
61
|
234
|
1z6eA |
Factor xa in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; dpc906; bms-561389) |
|
17
|
91
|
1xkbA |
Factor xa complexed with a synthetic inhibitor fx-2212a,(2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
|
14
|
91
|
1xkaL |
Factor xa complexed with a synthetic inhibitor fx-2212a,(2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
|
60
|
235
|
1xkbC |
Factor xa complexed with a synthetic inhibitor fx-2212a,(2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
|
64
|
235
|
1xkaC |
Factor xa complexed with a synthetic inhibitor fx-2212a,(2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
|
60
|
233
|
1wu1A |
Factor xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine |
|
4
|
86
|
1wheA |
Coagulation factor, nmr, 20 structures |
|
11
|
54
|
1wu1B |
Factor xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine |
|
4
|
86
|
1whfA |
Coagulation factor, nmr, 15 structures |
|
58
|
233
|
1v3xA |
Factor xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine |
|
12
|
52
|
1v3xB |
Factor xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine |
|
15
|
136
|
1p0sL |
Crystal structure of blood coagulation factor xa in complex with ecotin m84r |
|
57
|
235
|
1p0sH |
Crystal structure of blood coagulation factor xa in complex with ecotin m84r |
|
53
|
234
|
1nfwA |
Crystal structure of human coagulation factor xa complexed with rpr209685 |
|
12
|
53
|
1nfxB |
Crystal structure of human coagulation factor xa complexed with rpr208944 |
|
59
|
234
|
1nfxA |
Crystal structure of human coagulation factor xa complexed with rpr208944 |
|
12
|
53
|
1nfyB |
Crystal structure of human coagulation factor xa complexed with rpr200095 |
|
61
|
234
|
1nfyA |
Crystal structure of human coagulation factor xa complexed with rpr200095 |
|
12
|
52
|
1nfuB |
Crystal structure of human coagulation factor xa complexed with rpr132747 |
|
58
|
234
|
1nfuA |
Crystal structure of human coagulation factor xa complexed with rpr132747 |
|
10
|
51
|
1nfwB |
Crystal structure of human coagulation factor xa complexed with rpr209685 |
|
63
|
233
|
1mq6A |
Crystal structure of 3-chloro-n-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide complexed with human factor xa |
|
11
|
51
|
1mq5L |
Crystal structure of 3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide complexed with human factor xa |
|
13
|
51
|
1mq6L |
Crystal structure of 3-chloro-n-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide complexed with human factor xa |
|
59
|
233
|
1mq5A |
Crystal structure of 3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide complexed with human factor xa |
|
11
|
53
|
1lqdA |
Crystal structure of fxa in complex with 45. |
|
65
|
234
|
1lpkB |
Crystal structure of fxa in complex with 125. |
